Your shopping cart is currently empty

GNE-502, an orally active and potent estrogen receptor (ER) degrader, is specifically designed for breast cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $623 | Inquiry | Inquiry |
| Description | GNE-502, an orally active and potent estrogen receptor (ER) degrader, is specifically designed for breast cancer research. |
| In vivo | GNE-502, administered orally at doses of 10 and 100 mg/kg, demonstrates adequate oral bioavailability for evaluation in a WT MCF7 tumor xenograft mouse model. It exhibits dose-dependent tumor growth inhibition at 10 and 30 mg/kg and achieves tumor stasis at 100 mg/kg, indicative of its potential efficacy in cancer therapy. Dosage and administration details for pharmacokinetic analysis confirm its sufficient oral exposure for effectiveness in the specified model. |
| Molecular Weight | 471.59 |
| Formula | C25H30FN3O3S |
| Cas No. | 1953134-16-1 |
| Smiles | C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1S(C)(=O)=O)c1ccc(OCCN2CC(CF)C2)cc1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.